BTS
IMGN

BB&T Securities’s Immunogen Inc IMGN Stock Holding History

BB&T Securities’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$203K Sell
86,645
-2,028
-2% -$5.38K ﹤0.01% 1508
2019
Q2 		$192K Sell
88,673
-1,867
-2% -$4.42K ﹤0.01% 1539
2019
Q1 		$245K Buy
90,540
+22,721
+34% +$98.4K ﹤0.01% 1397
2018
Q4 		$325K Sell
67,819
-388
-0.6% -$2.35K ﹤0.01% 1161
2018
Q3 		$645K Sell
68,207
-4,972
-7% -$47.8K 0.01% 974
2018
Q2 		$712K Sell
73,179
-3,482
-5% -$36.7K 0.01% 936
2018
Q1 		$806K Sell
76,661
-10,870
-12% -$107K 0.01% 856
2017
Q4 		$561K Buy
87,531
+2,192
+3% +$13.5K 0.01% 954
2017
Q3 		$652K Sell
85,339
-4,726
-5% -$31.4K 0.01% 892
2017
Q2 		$640K Buy
90,065
+56,008
+164% +$256K 0.01% 894
2017
Q1 		$131K Sell
34,057
-200
-0.6% -$584 ﹤0.01% 1203
2016
Q4 		$91K Hold
34,257
– – ﹤0.01% 1189
2016
Q3 		$91K Buy
34,257
+5,049
+17% +$14.7K ﹤0.01% 1197
2016
Q2 		$89K Buy
29,208
+6,481
+29% +$40.6K ﹤0.01% 1186
2016
Q1 		$193K Buy
22,727
+2,065
+10% +$17.5K ﹤0.01% 1092
2015
Q4 		$280K Sell
20,662
-361
-2% -$4.44K 0.01% 945
2015
Q3 		$201K Buy
21,023
+562
+3% +$8.22K ﹤0.01% 1007
2015
Q2 		$294K Sell
20,461
-6,933
-25% -$76.1K 0.01% 909
2015
Q1 		$245K Buy
27,394
+11,710
+75% +$84.8K 0.01% 948
2014
Q4 		$95.6K Buy
15,684
+4,927
+46% +$45.1K ﹤0.01% 1061
2014
Q3 		$114K Buy
+10,757
New +$122K ﹤0.01% 1007

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BB&T Securities's IMGN Position: Q3 2019 in Review

BB&T Securities reduced its Immunogen Inc (IMGN) stake by 2.3% in Q3 2019, selling an estimated $5.38K and leaving 86,645 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #1508.

BB&T Securities first reported a position in IMGN in Q3 2014 and has held it in 21 quarters since. The position peaked at $806K in Q1 2018. 189 funds tracked by Wall St. Rank hold IMGN as of Q3 2019.

  • BB&T Securities held 86,645 shares of Immunogen Inc worth $203K as of Q3 2019.
  • BB&T Securities sold 2,028 Immunogen Inc shares in Q3 2019, an estimated $5.38K.
  • Immunogen Inc made up ﹤0.01% of BB&T Securities's portfolio in Q3 2019, its #1508 holding.
  • BB&T Securities first reported a position in Immunogen Inc in Q3 2014 and has held it in 21 quarters since.
  • BB&T Securities's Immunogen Inc position peaked at $806K in Q1 2018.
  • 189 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.